Ancient acupoint plaster could cut opioid use in cancer pain
NCT ID NCT07657390
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether a traditional Chinese herbal plaster called Gutong Plaster, applied to specific acupoints, can improve pain relief and reduce opioid use in adults with moderate to severe cancer pain. Participants receive either the real plaster or a placebo alongside standard oxycodone treatment for 14 days. The study measures pain scores, opioid consumption, and quality of life to see if adding the plaster makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gutong Plaster (herbal mixture applied to acupoints)
- What this could lead to
- If it works, this could offer a non-drug way to boost pain control and lower the need for strong opioids in cancer patients.
- What could go wrong
- This is an early-phase trial with only 198 participants, so results may not apply broadly. The plaster may not provide meaningful extra pain relief over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER PAINS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
RECRUITINGBeijing, 100700, China